<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02924896</url>
  </required_header>
  <id_info>
    <org_study_id>16/WA/0117</org_study_id>
    <nct_id>NCT02924896</nct_id>
  </id_info>
  <brief_title>Effect of Palm Olein Intake on Lipid Profile and Appetite Regulation</brief_title>
  <acronym>APO</acronym>
  <official_title>The Chemical Structure of a Lipid Determines Its Effect on Blood Lipid Profile and Appetite Regulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Malaysia Palm Oil Board</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aims: To investigate whether acute ingestions of palm oil will have an effect on appetite
      regulation

      Design: A randomized, single blind, cross over design including 4 single study visits
      separated by a week. Visit 1 is an acclimatization visit followed by visit 2,3, and 4 where
      different types of fat will be given.

      Population: 12 healthy males and females aged between 18 and 60 years with body mass index
      (BMI) between 18.5- 29.9kg/m2 and normal fasting plasma glucose and no evidence of insulin
      resistance will be recruited. No-pre existing morbidity including cardiac, hepatic or renal
      disease, history of diabetes, hypertension or hyperlipidaemia.

      Treatment: Acclimatization visit: At visit 1, all participants will be given a milkshake like
      drink containing fat, protein and carbohydrate. A cannula will be inserted for the duration
      of the study day but no blood will be taken. Studies show than during the first visit stress
      response can affect the metabolic response to the study drink resulting in inaccurate
      results.

      Study visit 2,3,4: following the acclimatization visit, participants will attend 3 more study
      visits separated by a week to test the metabolic response to the following fats: palm olein,
      interesterified palm olein and soybean oil in random order. Participants will be asked to
      complete a visual analogue scale questionnaire about their appetite at each time point.
      Fasting and postprandial plasma glucose, insulin, appetite hormones and lipids will be
      measured.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Actual">April 2017</completion_date>
  <primary_completion_date type="Actual">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change from baseline in appetite hormones</measure>
    <time_frame>time (minutes)=-15, -5, 15, 30, 45, 60, 90, 120, 180, 240, 300, 360, 420, 480</time_frame>
    <description>blood samples will be collected at specific time points presented as minutes from consumption of mixed meal</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change from baseline in lipids</measure>
    <time_frame>time (minutes)=-15, -5, 15, 30, 45, 60, 90, 120, 180, 240, 300, 360, 420, 480</time_frame>
    <description>blood samples will be collected at specific time points presented as minutes from consumption of mixed meal</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Lipidaemia</condition>
  <arm_group>
    <arm_group_label>randomization 1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Palm Olein, Interesterified Palm Olein, Soybean Oil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>randomization 2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Palm Olein, Soybean Oil, Interesterified Palm Olein</description>
  </arm_group>
  <arm_group>
    <arm_group_label>randomization 3</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Interesterified Palm Olein, Palm Olein, Soybean Oil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>randomization 4</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Interesterified Palm Olein, Soybean Oil, Palm Olein</description>
  </arm_group>
  <arm_group>
    <arm_group_label>randomization 5</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Soybean Oil, Interesterified Palm Olein, Palm Olein</description>
  </arm_group>
  <arm_group>
    <arm_group_label>randomization 6</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Soybean Oil, Palm Olein, Interesterified Palm Olein</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Palm olein</intervention_name>
    <description>60g of palm olein will be given in a milkshake at breakfast</description>
    <arm_group_label>randomization 1</arm_group_label>
    <arm_group_label>randomization 2</arm_group_label>
    <arm_group_label>randomization 3</arm_group_label>
    <arm_group_label>randomization 4</arm_group_label>
    <arm_group_label>randomization 5</arm_group_label>
    <arm_group_label>randomization 6</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Interesterified palm olein</intervention_name>
    <description>60g of interesterified palm olein will be given in a milkshake at breakfast</description>
    <arm_group_label>randomization 1</arm_group_label>
    <arm_group_label>randomization 2</arm_group_label>
    <arm_group_label>randomization 3</arm_group_label>
    <arm_group_label>randomization 4</arm_group_label>
    <arm_group_label>randomization 5</arm_group_label>
    <arm_group_label>randomization 6</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Soybean oil</intervention_name>
    <description>60g of soybean oil will be given in a milkshake at breakfast</description>
    <arm_group_label>randomization 1</arm_group_label>
    <arm_group_label>randomization 2</arm_group_label>
    <arm_group_label>randomization 3</arm_group_label>
    <arm_group_label>randomization 4</arm_group_label>
    <arm_group_label>randomization 5</arm_group_label>
    <arm_group_label>randomization 6</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy and overweight male and female volunteers of all ethnicities (body mass index
             (BMI) of 18.5-29.9 kg/m2)

          -  Age between 18-60 years (inclusive)

        Exclusion Criteria:

          -  Abnormal liver function test (elevated alanine aminotransferase and aspartate
             transaminase)/ abnormal kidney function test (elevated plasma creatinine)

          -  History of type 2 diabetes mellitus, cancer, stomach ulcers, drug abuse or alcoholism,
             gastrointestinal disorders like Crohn's disease

          -  Smokers

          -  On lipid/blood pressure- lowering medication/supplements

          -  Blood pressure&gt;140/90 mm Hg

          -  Fasting total cholesterol &gt; 6.2 mmol/L

          -  Fasting triacylglyceride &gt; 2.0 mmol/L

          -  Subject must not be allergic to intervention

          -  Pregnancy and breastfeeding (pregnancy test will be undertaken at the screening visit)

          -  Subjects taking nutritional supplements or on any weight-loss programs

          -  Subjects who gained or lost â‰¥ 3kg weight in the past three months

          -  Subjects with history of hypo- and hyperthyroidism

          -  Subjects who are anaemic and those who donated blood within three months of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gary Frost</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NIHR/Wellcome Trust Imperial Clinical Research Facility</name>
      <address>
        <city>London</city>
        <zip>W12 0HS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://imperial.crf.nihr.ac.uk/</url>
    <description>Clinical Research Facility official web page</description>
  </link>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 28, 2016</study_first_submitted>
  <study_first_submitted_qc>October 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 5, 2016</study_first_posted>
  <last_update_submitted>March 8, 2018</last_update_submitted>
  <last_update_submitted_qc>March 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperlipidemias</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

